Asia Pacific Pregnancy and Ovulation Testing Market Research Report – Forecast to 2027

Asia Pacific Pregnancy & Ovulation Testing Market Research Report: By Type (hCG Detection, Ovulation Testing), by Mode of Purchase (OTC Testing, Prescription Testing), End-User (Hospitals & Clinics, Fertility Centers, Others) - Forecast Till 2027

ID: MRFR/HC/4739-CR | July 2018 | Region: Bric | 91 pages

Asia Pacific Pregnancy & Ovulation Testing Market Overview

The Asia Pacific pregnancy & ovulation testing market is anticipated to touch USD 298.68 billion by 2023, as per an insightful report by Market Research Future (MRFR). It is expected to exhibit a 6.1% CAGR during the assessment period (2018-2023). The increasing acceptance of home testing kits to check the possibility of pregnancy is projected to spur market demand during the forecast period.

Pregnancy tests are kits capable of detecting hormones such as human chorionic gonadotropin (hCG) in urine. Ovulation tests, on the other hand, are capable of detecting an uptick in luteinizing hormone (LH) to decide the optimal time for conceiving children. Availability of ovulation monitors on e-commerce websites, awareness of fertility tests, and awareness of these tests made possible by various promotional marketing activities by major brands are likely to lead to an uptick in market demand over the forecast period.


Digitization of results to provide privacy to consumers has been made possible owing to pervasiveness of smartphones. For instance, the FIRST RESPONSE Pregnancy PRO Digital Test & App Access by Church & Dwight Co., sends accurate results to the consumer’s smartphone. But high costs of ovulation tests can act as a market deterrent.


Report Overview


This report allows the user to gain a deeper understanding of the ongoing events and trends in the Asia Pacific (APAC) market for pregnancy and ovulation testing. By correlating the historical data with key market dynamics, our analysts can make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the APAC market segmented by type, mode of purchase, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.


Segment Overview


By type, the Asia Pacific pregnancy & ovulation testing market has been segmented into pregnancy and ovulation testing. The pregnancy testing segment is sub-segmented into blood-based and urine-based testing. This segment is touted to garner above average demand owing to advances in pregnancy testing kits and alarming cases of polycystic ovary syndrome (PCOS). Similarly, the ovulation testing segment is sub-segmented into fertility monitors and ovulation prediction kits.


By mode of purchase, the Asia Pacific pregnancy & ovulation testing market is segmented into prescription and non-prescription testing/over-the-counter (OTC) testing.  The non-prescription testing mode of purchase is projected to experience remarkable growth thanks to preference for home pregnancy tests and privacy concerns among women.


By end-user, the Asia Pacific pregnancy & ovulation testing market is segmented into fertility centers, hospitals and clinics, and others. The hospitals and clinics segment is likely to register a 5.8% CAGR during the forecast period owing to their propensity to handle large patient volumes.


The segments and sub-segments covered in the report are analyzed under six major regions – India, China, Japan, Republic of Korea, Australia, and Rest of Asia Pacific, with respective country-level market sizing. For the scope of research, the standard definition of the product/service “pregnancy and ovulation testing” is included in the report. The report discusses and interprets the current and future opportunities of the industry by delivering an unbiased growth assessment.


Players Covered


Gregory Pharmaceutical Holdings, Inc., Proctor & Gamble, TaiDoc Technology & Corporation, Mankind Pharma Ltd., Geratherm Medical AG, Fairhaven Health, LLC, Quidel Corporation, Piramal Enterprises Ltd., Cadila Healthcare Limited, and Church & Dwight Co., Inc., are noteworthy players in the Asia Pacific pregnancy and ovulation testing market.


The report offers comprehensive profiles on these market players and assesses their current standing in the Asia Pacific pregnancy and ovulation testing market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are outlined in the report.


Research Methodology


Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report comprises news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.


Analysis Period



  • Base Year - 2017

  • Projection Period - From 2018 to 2023

  • Market Denomination - USD Billion

  • Conversion Rate - Considered as per the respective financial years


Intended Audience



  • Government Research Institutes

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Academic Institutes and Universities


For the scope of research, the report offers a comprehensive analysis of the Asia Pacific pregnancy and ovulation testing market.


Type



  • Pregnancy Testing (hCG Detection)

    • Urine-based Testing

    • Blood-based Testing



  • Ovulation Testing

    • Ovulation Prediction Kits

    • Fertility Monitors




Mode of Purchase



  • Prescription Testing

  • Non-prescription or OTC Testing


End-user



  • Fertility Centers

  • Hospitals & Clinics

  • Others


Region



  • Australia

  • Republic of Korea

  • India

  • China

  • Japan

  • Rest of Asia Pacific



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 15

3.2 Scope Of The Study 15

3.3 Assumptions & Limitations 15

3.3.1 Assumptions 15

3.3.2 Limitations 15

3.4 Market Structure 16

4 Research Methodology

4.1 Research Process 18

4.2 Primary Research 19

4.3 Secondary Research 20

4.4 Market Size Estimation 21

5 Market Dynamics

5.1 Introduction 23

5.2 Drivers 24

5.2.1 Declining Fertility Rate 24

5.2.2 Emergence Of Advanced Technology With High Accuracy 24

5.2.3 Easy Availability Of Ovulation & Pregnancy Monitors On E-Commerce Websites 25

5.3 Restraints 25

5.3.1 High Cost Associated With Ovulation Tests 25

5.4 Opportunities 25

5.4.1 Growing Awareness About Pregnancy And Ovulation Testing 25

6 Market Factor Analysis

6.1 Porter’s Five Forces Analysis 27

6.1.1 Bargaining Power Of Suppliers 27

6.1.2 Bargaining Power Of Buyers 28

6.1.3 Threat Of New Entrants 28

6.1.4 Threat Of Substitutes 28

6.1.5 Intensity Of Rivalry 28

6.2 Supply Chain Analysis 29

6.2.1 R&D 29

6.2.2 Parts Manufacturing 29

6.2.3 Distribution 29

6.2.4 Marketing & Sales 29

6.2.5 Post-Sales Monitoring 30

6.3 Pricing Analysis 30

6.4 Investment Opportunities 30

7 Asia Pacific Pregnancy & Ovulation Testing Market, By Product Type

7.1 Overview 32

7.1.1 Introduction 32

7.1.2 Pregnancy Testing (HCG Detection) 33

7.1.2.1 Urine-Based Testing 35

7.1.2.2 Blood-Based Testing 35

7.1.3 Ovulation Testing 36

7.1.3.1 Ovulation Prediction Kits 38

7.1.3.2 Fertility Monitors 38

8 Asia Pacific Pregnancy & Ovulation Testing Market, By Mode Of Purchase

8.1 Overview 40

8.1.1 Introduction 40

8.1.2 Non-Prescription Or OTC Testing 41

8.1.3 Prescription Testing 42

9 Asia Pacific Pregnancy & Ovulation Testing Market, By End-User

9.1 Overview 44

9.1.1 Introduction 44

9.1.2 Hospitals & Clinics 45

9.1.3 Fertility Centres 46

9.1.4 Others 46

10 Asia Pacific Pregnancy & Ovulation Testing Market, By Country/Region

10.1 Asia Pacific 48

10.1.1 Japan 51

10.1.2 China 53

10.1.3 India 55

10.1.4 Republic Of Korea 57

10.1.5 Australia 59

10.1.6 Rest Of Asia Pacific 61

11 Competitive Landscape

11.1 Introduction 64

11.2 Company Share Analysis 64

12 Company Profiles

12.1 SPD Swiss Precision Diagnostics GmbH 66

12.1.1 Company Overview 66

12.1.2 Financial Overview 66

12.1.3 Products Offering 67

12.1.4 Key Developments 67

12.1.5 SWOT Analysis 67

12.1.6 Key Strategy 68

12.2 Fairhaven Health, LLC 69

12.2.1 Company Overview 69

12.2.2 Financial Overview 69

12.2.3 Products Offering 69

12.2.4 Key Developments 69

12.2.5 SWOT Analysis 70

12.2.6 Key Strategy 70

12.3 Church & Dwight Co., Inc. 71

12.3.1 Company Overview 71

12.3.2 Financial Overview 71

12.3.3 Products Offering 72

12.3.4 Key Developments 72

12.3.5 SWOT Analysis 72

12.3.6 Key Strategy 72

12.4 Piramal Enterprises Ltd. 73

12.4.1 Company Overview 73

12.4.2 Financial Overview 73

12.4.3 Products Offering 74

12.4.4 Key Developments 74

12.4.5 SWOT Analysis 74

12.4.6 Key Strategy 74

12.5 Quidel Corporation 75

12.5.1 Company Overview 75

12.5.2 Financial Overview 75

12.5.3 Products Offering 76

12.5.4 Key Developments 76

12.5.5 SWOT Analysis 76

12.5.6 Key Strategy 76

12.6 Mankind Pharma Ltd. 77

12.6.1 Company Overview 77

12.6.2 Financial Overview 77

12.6.3 Products Offering 78

12.6.4 Key Developments 78

12.6.5 SWOT Analysis 78

12.6.6 Key Strategy 78

12.7 TaiDoc Technology & Corporation 79

12.7.1 Company Overview 79

12.7.2 Financial Overview 79

12.7.3 Products Offering 79

12.7.4 Key Developments 80

12.7.5 SWOT Analysis 80

12.7.6 Key Strategy 80

12.8 Cadila Healthcare Limited 81

12.8.1 Company Overview 81

12.8.2 Financial Overview 81

12.8.3 Products Offering 82

12.8.4 Key Developments 82

12.8.5 SWOT Analysis 82

12.8.6 Key Strategy 82

12.9 Gregory Pharmaceutical Holdings, Inc. 83

12.9.1 Company Overview 83

12.9.2 Financial Overview 83

12.9.3 Products Offering 83

12.9.4 Key Developments 83

12.9.5 SWOT Analysis 83

12.9.6 Key Strategy 84

13 Appendix

13.1 Discussion Blue Print 86

13.2 References 87

14 List Of Tables

TABLE 1 MARKET SYNOPSIS 13

TABLE 2 PRIMARY INTERVIEWS 18

TABLE 3 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET BY PRODUCT TYPE, 2020-2027 (USD MILLION) 33

TABLE 4 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR PREGNANCY TESTING (HCG DETECTION), BY TYPE, 2020-2027 (USD MILLION) 33

TABLE 5 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR PREGNANCY TESTING (HCG DETECTION), BY COUNTRY/REGION, 2020-2027 (USD MILLION) 34

TABLE 6 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR URINE-BASED TESTING, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 35

TABLE 7 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR BLOOD-BASED TESTING, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 35

TABLE 8 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR OVULATION TESTING, BY TYPE, 2020-2027 (USD MILLION) 36

TABLE 9 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 37

TABLE 10 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR OVULATION TESTING, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 37

TABLE 11 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR OVULATION PREDICTION KITS, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 38

TABLE 12 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 38

TABLE 13 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 41

TABLE 14 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR NON-PRESCRIPTION OR OTC TESTING, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 41

TABLE 15 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR PRESCRIPTION TESTING, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 42

TABLE 16 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET BY END-USER, 2020-2027 (USD MILLION) 45

TABLE 17 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 45

TABLE 18 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY CENTRES, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 46

TABLE 19 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY COUNTRY/REGION, 2020-2027 (USD MILLION) 49

TABLE 20 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 49

TABLE 21 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 49

TABLE 22 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 50

TABLE 23 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 24 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 50

TABLE 25 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 50

TABLE 26 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 51

TABLE 27 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 51

TABLE 28 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 51

TABLE 29 JAPAN: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 51

TABLE 30 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 52

TABLE 31 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 52

TABLE 32 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 53

TABLE 33 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 53

TABLE 34 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 53

TABLE 35 CHINA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 53

TABLE 36 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 54

TABLE 37 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 54

TABLE 38 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 55

TABLE 39 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 55

TABLE 40 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 55

TABLE 41 INDIA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 55

TABLE 42 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 56

TABLE 43 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 56

TABLE 44 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 57

TABLE 45 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 57

TABLE 46 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 57

TABLE 47 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 58

TABLE 48 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 58

TABLE 49 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 58

TABLE 50 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 59

TABLE 51 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 59

TABLE 52 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 59

TABLE 53 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 54 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 60

TABLE 55 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 60

TABLE 56 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 61

TABLE 57 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2020-2027 (USD MILLION) 61

TABLE 58 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2020-2027 (USD MILLION) 61

TABLE 59 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 60 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020-2027 (USD MILLION) 62

TABLE 61 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020-2027 (USD MILLION) 62

15 List Of Figures

FIGURE 1 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET: MARKET STRUCTURE 16

FIGURE 2 RESEARCH PROCESS 18

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 21

FIGURE 4 MARKET DYNAMICS ANALYSIS OF ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET 23

FIGURE 5 PORTERS FIVE FORCES ANALYSIS OF ASIA PACIFIC PREGNANCY AND OVULATION TESTING MARKET 27

FIGURE 6 SUPPLY CHAIN: ASIA PACIFIC PREGNANCY AND OVULATION TESTING MARKET 29

FIGURE 7 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020 (% SHARE) 32

FIGURE 8 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 32

FIGURE 9 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020 (% SHARE) 40

FIGURE 10 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2020 & 2027 (USD MILLION) 40

FIGURE 11 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020 (% SHARE) 44

FIGURE 12 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2020 & 2027 (USD MILLION) 44

FIGURE 13 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET SHARE, BY COUNTRY/REGION, 2020 (%) 48

FIGURE 14 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, MARKET SHARE ANALYSIS 2020 (%) 64



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Asia Pacific Pregnancy and Ovulation Testing Market: Competitive Landscape


Church & Dwight Co., Inc., SPD Swiss Precision Diagnostics GmbH, and Mankind Pharma Ltd collectively accounted for around 28.1% market share of Asia Pacific pregnancy and ovulation testing market in 2017. These companies continue to retain their strong presence through product launch, and FDA approval. As there are plenty of large and small market players available, it is very tricky to analyze their market shares.


SPD Swiss Precision Diagnostics GmbH accounted for the largest market share of the Asia Pacific pregnancy and ovulation testing market. Church & Dwight Co., Inc. accounts for approximately 9.4% share in the pregnancy and ovulation testing market. Mankind Pharma Ltd holds the third position in the Asia Pacific pregnancy and ovulation testing market owing to strong brand value.


In 2017, SPD Swiss Precision Diagnostics GmbH accounted for the largest market share of Asia Pacific pregnancy and ovulation testing market, with around 12.2% of the market share. The large share of the company is attributed to the launch of new products at a very competitive price such as Clearblue Pregnancy Test with Weeks indicator, Clearblue Early Detection Pregnancy Test, Clearblue Rapid Detection Pregnancy Test, Clearblue Digital Early Detection Pregnancy Test, Clearblue Fast & Easy Pregnancy Test, Clearblue Advanced Fertility Monitor, Clearblue Advanced Digital Ovulation Test, Clearblue Digital Ovulation Test, and others. In the last few years, the company has adopted the strategy of introducing a new product by focusing on R&D. For instance, in 2017, The Company launched the Clearblue Connected Ovulation Test System, the first and only ovulation test system to track two unique hormones with smartphone connectivity.


Church & Dwight Co., Inc. held the second position in terms of market share, in 2017. The company focuses on developing and distributing innovative products, which differentiate them from other players around the globe. For instance, in Jan 2016, the company launched FIRST RESPONSE Pregnancy PRO Digital Test & App Access. With this launch, the company expanded its pregnancy test product portfolio. Moreover, the company has a strategy of rising the global market presence through mergers and acquisitions. The company offers products under various brands such as OXICLEAN, ARM & HAMMER, TROJAN, SPINBRUSH, NAIR, ORAJEL, XTRA, FIRST RESPONSE, L’IL CRITTERS, BATISTE, WATERPIK, and VITAFUSION. Church & Dwight Co., Inc. sells home pregnancy and ovulation kits under the FIRST RESPONSE brand such as first response rapid result pregnancy test, first response early result pregnancy test, first response gold digital pregnancy test, first response triple check pregnancy test kit, first response pregnancy pro, and first response daily digital ovulation test


Mankind Pharma Ltd acquired the third spot in the market. The company currently has a presence in 22 countries across Asia, Africa, South-East Asia, and Gulf countries and focused on increasing its worldwide market presence. For instance, Mankind Pharma has set its manufacturing units in the U.S. (September 2017)


There are many other players present in the market such as, Fairhaven Health, LLC, Piramal Enterprises Ltd, Quidel Corporation, TaiDoc Technology & Corporation, Cadila Healthcare Limited, Gregory Pharmaceutical Holdings, Inc. and others that accounts around 71.9% of the Asia Pacific market share. The companies adopted the strategy of FDA approvals and acquisitions to solidify their position in the market.